Rationale and design of the beta-blockers in tako- tsubo syndrome study: a randomized clinical trial (β-Tako)
Published in Rev Esp Cardiol (Engl Ed), 2025
Recommended citation: Alfonso F, Salamanca J, Núñez-Gil I, Ibáñez B, Sanchis J, Sabaté M, Velázquez M, Raposeiras-Roubín S, García-Camarero T, Antuña P, Mejía H, Carrillo X, Buera I, Martínez-Sellés M, Escudier-Villa JM, Sánchez-Prieto J, Blanco Ponce E, Cabezón G, Fernández-Golfín C, Pascual-Figal D, Cid B, Marcano A, González- Manzanares R , Jiménez-Valero S, Vázquez JM, Sanz-Sánchez J, Cecconi A, Del Val D, Abad-Santos F, Crea F. Rationale and design of the beta-blockers in tako- tsubo syndrome study: a randomized clinical trial (β-Tako). Rev Esp Cardiol (Engl Ed). 2025 Jul;78(7):592-599. English, Spanish. doi: 10.1016/j.rec.2024.12.006. Epub 2024 Dec 30. PMID: 39743172.
Download Paper